Silent Myocardial Ischemia: From Pathophysiology to Diagnosis and Treatment
Panagiotis Theofilis1, Alexios S Antonopoulos1, Marios Sagris1
11st Department of Cardiology, "Hippokration" General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
Insights
Silent myocardial ischemia (SMI) involves inadequate heart blood flow without chest pain. This review covers its causes, diagnosis using advanced imaging, and controversial treatment options for better patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Ischemic Heart Disease
Background:
- Silent myocardial ischemia (SMI) presents without typical symptoms, complicating diagnosis and management.
- Pathogenesis involves complex vascular, neurohormonal, and metabolic interactions leading to myocardial hypoperfusion.
- Recognizing SMI's diverse clinical manifestations is crucial for effective intervention.
Purpose of the Study:
- To provide a comprehensive review of silent myocardial ischemia.
- To elucidate the underlying pathophysiology of SMI.
- To discuss current diagnostic and therapeutic strategies for SMI.
Main Methods:
- Literature review synthesizing current knowledge on SMI.
- Analysis of diagnostic modalities including ECG, stress echocardiography, SPECT, PET, and MRI.
- Evaluation of evidence regarding invasive versus medical management for SMI.
Main Results:
- SMI pathogenesis is multifactorial, involving vascular, neurohormonal, and metabolic factors.
- Advanced imaging techniques offer improved diagnostic capabilities for SMI.
- Treatment strategies for SMI remain a subject of debate, with controversial evidence on invasive vs. medical management.
Conclusions:
- Silent myocardial ischemia requires a thorough understanding of its complex pathophysiology.
- A range of diagnostic tools are available, with advanced imaging playing a key role.
- Further research is needed to clarify optimal therapeutic approaches for SMI.
Abstract:
Silent myocardial ischemia (SMI), characterized by a lack of overt symptoms despite an inadequate blood supply to the myocardium, remains a challenging entity in cardiovascular medicine. The pathogenesis involves intricate interactions of vascular, neurohormonal, and metabolic factors, contributing to perfusion deficits without the characteristic chest pain. Understanding these mechanisms is pivotal for recognizing diverse clinical presentations and designing targeted interventions. Diagnostic strategies for SMI have evolved from traditional electrocardiography to advanced imaging modalities, including stress echocardiography, single-photon emission computed tomography (SPECT), positron emission tomography (PET), and cardiac magnetic resonance imaging (MRI). Treating SMI is a matter of ongoing debate, as the available evidence on the role of invasive versus medical management is controversial. This comprehensive review synthesizes current knowledge of silent myocardial ischemia, addressing its pathophysiology, diagnostic modalities, and therapeutic interventions.
Related Concept Videos
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
01:17Pathophysiology of Heart Failure
01:29Pathophysiology of Cardiac Performance
01:17Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...